WeVote

Bill

Bill

SB 968

AN ACT PROHIBITING COMMERCIAL ACTIVITIES INVOLVING FOOD PRODUCTS THAT CONTAIN CERTAIN FOOD ADDITIVES.

2025 Regular Session Introduced by Heather Somers

Connecticut bill prohibits commercial sale of foods with certain additives, potentially restricting products and raising compliance costs for manufacturers and consumers.

REF. TO JOINT COMM. ON General Law
0
WeVote Research Nonpartisan
Bill Summary · SB 968

Legislative bill overview

SB 968 would prohibit the commercial sale and distribution of food products containing certain food additives that the bill identifies as harmful or restricted. The specific additives targeted are not detailed in the title alone, but the bill establishes a mechanism to ban these substances from Connecticut's commercial food supply. This would make Connecticut one of the stricter states regarding food additive regulations.

Why is this important

Food additive regulations directly affect consumer health and food industry operations. If the bill targets additives like artificial dyes, brominated vegetable oil, or other substances already restricted in other countries, it could set a precedent for stricter U.S. food safety standards. Conversely, it could increase food costs for consumers and create compliance challenges for manufacturers operating across multiple states with different regulations.

Potential points of contention

  • Scope and specificity: Without knowing which additives are targeted, businesses cannot assess compliance costs; overly broad language could inadvertently ban common preservatives
  • Interstate commerce conflicts: Connecticut alone restricting additives while federal FDA approval stands could create supply chain complications and consumer access issues
  • Economic impact: Food manufacturers may need to reformulate products solely for Connecticut, raising costs that could be passed to consumers or limiting product availability in the state
  • Scientific basis: The bill's credibility depends on whether targeted additives are based on peer-reviewed evidence or precautionary approaches that may differ from FDA determinations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.